Literature DB >> 24566976

Gene therapies for arrhythmias in heart failure.

Fadi G Akar1, Roger J Hajjar.   

Abstract

In this article, we review recent advances in our understanding of arrhythmia mechanisms in the failing heart. We focus on changes in repolarization, conduction, and intracellular calcium cycling because of their importance to the vast majority of clinical arrhythmias in heart failure. We highlight recent efforts to combat arrhythmias using gene-based approaches that target ion channel, gap junction, and calcium cycling proteins. We further discuss the advantages and limitations associated with individual approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566976      PMCID: PMC4070506          DOI: 10.1007/s00424-014-1485-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  69 in total

Review 1.  Electrophysiological remodeling in hypertrophy and heart failure.

Authors:  G F Tomaselli; E Marbán
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

Review 2.  The Brugada syndrome: ionic basis and arrhythmia mechanisms.

Authors:  C Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2001-02

Review 3.  Gene therapy for ventricular tachyarrhythmias.

Authors:  J K Donahue
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

4.  Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy.

Authors:  Hongwei Jin; Elie R Chemaly; Ahyoung Lee; Changwon Kho; Lahouaria Hadri; Roger J Hajjar; Fadi G Akar
Journal:  FASEB J       Date:  2009-10-13       Impact factor: 5.191

5.  A mechanism of transition from ventricular fibrillation to tachycardia : effect of calcium channel blockade on the dynamics of rotating waves.

Authors:  F H Samie; R Mandapati; R A Gray; Y Watanabe; C Zuur; J Beaumont; J Jalife
Journal:  Circ Res       Date:  2000-03-31       Impact factor: 17.367

6.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Authors:  Mariell Jessup; Barry Greenberg; Donna Mancini; Thomas Cappola; Daniel F Pauly; Brian Jaski; Alex Yaroshinsky; Krisztina M Zsebo; Howard Dittrich; Roger J Hajjar
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

Review 7.  Gene therapy strategies for cardiac electrical dysfunction.

Authors:  Ian Greener; J Kevin Donahue
Journal:  J Mol Cell Cardiol       Date:  2010-08-07       Impact factor: 5.000

8.  Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans.

Authors:  Michael J Cutler; Xiaoping Wan; Kenneth R Laurita; Roger J Hajjar; David S Rosenbaum
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

9.  Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

Authors:  Brian E Jaski; Mariell L Jessup; Donna M Mancini; Thomas P Cappola; Daniel F Pauly; Barry Greenberg; Kenneth Borow; Howard Dittrich; Krisztina M Zsebo; Roger J Hajjar
Journal:  J Card Fail       Date:  2009-04       Impact factor: 5.712

10.  SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.

Authors:  Alexander R Lyon; Mark L Bannister; Tom Collins; Emma Pearce; Amir H Sepehripour; Sukhpreet S Dubb; Edwin Garcia; Peter O'Gara; Lifan Liang; Erik Kohlbrenner; Roger J Hajjar; Nicholas S Peters; Philip A Poole-Wilson; Ken T Macleod; Sian E Harding
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-15
View more
  3 in total

Review 1.  Toward microendoscopy-inspired cardiac optogenetics in vivo: technical overview and perspective.

Authors:  Aleksandra Klimas; Emilia Entcheva
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

Review 2.  Gene therapy to restore electrophysiological function in heart failure.

Authors:  Lukas J Motloch; Fadi G Akar
Journal:  Expert Opin Biol Ther       Date:  2015-04-12       Impact factor: 4.388

Review 3.  Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy.

Authors:  Vera Paar; Peter Jirak; Robert Larbig; Naufal Shamilevich Zagidullin; Mathias C Brandt; Michael Lichtenauer; Uta C Hoppe; Lukas J Motloch
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.